Publicaciones en colaboración con investigadores/as de University Hospital Heidelberg (7)

2024

  1. Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease

    Annals of Surgical Oncology, Vol. 31, Núm. 10, pp. 6495-6503

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

2022

  1. Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

    Liver International, Vol. 42, Núm. 12, pp. 2855-2870

2020

  1. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis

    Journal of Pathology, Vol. 252, Núm. 3, pp. 239-251

2019

  1. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice

    Gastroenterology, Vol. 156, Núm. 4, pp. 1190-1205.e14

  2. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury

    Cell Death and Differentiation, Vol. 26, Núm. 12, pp. 2710-2726